Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs PPL Corporation Common Stock (PPL) Price & Performance

Nuvation Bio Inc. Class A Common StockTrade
PPL Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Nuvation Bio Inc. Class A Common Stock vs PPL Corporation Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while PPL Corporation Common Stock trades at $34.08 (market cap $25.55B). The key difference: PPL Corporation Common Stock is far larger — about 14.9× Nuvation Bio Inc. Class A Common Stock's market cap, and PPL Corporation Common Stock pays a 3.36% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and PPL Corporation Common Stock for 0 Days on average.

NUVBPPL
Market Cap
$1.71B$25.55B
Volume
5,448,7126,874,595
Sector
HealthUtilities
52-Week High
$9.54$39.81
52-Week Low
$3.41$31.97
Typical Hold Time
0 Days0 Days
Enterprise Value
$1.30B$45.54B
Dividend Yield
—3.36%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUVB
100% Buy0% Sell
Avg holding period · 0 Days
PPL
100% Buy0% Sell
Avg holding period · 0 Days

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →

About PPL Corporation Common Stock

PPL Corporation is a regulated utility holding company. Through its subsidiaries, it generates, transmits, distributes, and sells electricity and natural gas in Kentucky, Pennsylvania, and Rhode Island.

Read more on PPL →